Cargando…

Screening of FDA-Approved Drugs Using a 384-Well Plate-Based Biofilm Platform: The Case of Fingolimod

In an effort to find new repurposed antibacterial compounds, we performed the screening of an FDA-approved compounds library against Staphylococcus aureus American Type Culture Collection (ATCC) 25923. Compounds were evaluated for their capacity to prevent both planktonic growth and biofilm formatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilbert-Girard, Shella, Savijoki, Kirsi, Yli-Kauhaluoma, Jari, Fallarero, Adyary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700524/ https://www.ncbi.nlm.nih.gov/pubmed/33233348 http://dx.doi.org/10.3390/microorganisms8111834

Ejemplares similares

Optimization of a High-Throughput 384-Well Plate-Based Screening Platform with Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 15442 Biofilms
por: Gilbert-Girard, Shella, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of Fingolimod Derivatives as Antibacterial Agents
por: Zore, Matej, et al.
Publicado: (2021)

Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria
por: Zore, Matej, et al.
Publicado: (2022)

Strategies to Prevent Biofilm Infections on Biomaterials: Effect of Novel Naturally-Derived Biofilm Inhibitors on a Competitive Colonization Model of Titanium by Staphylococcus aureus and SaOS-2 Cells
por: Reigada, Inés, et al.
Publicado: (2020)

Combined Effect of Naturally-Derived Biofilm Inhibitors and Differentiated HL-60 Cells in the Prevention of Staphylococcus aureus Biofilm Formation
por: Reigada, Inés, et al.
Publicado: (2020)

Surfaceome and Exoproteome Dynamics in Dual-Species Pseudomonas aeruginosa and Staphylococcus aureus Biofilms
por: Reigada, Inés, et al.
Publicado: (2021)

Surface-Shaving Proteomics of Mycobacterium marinum Identifies Biofilm Subtype-Specific Changes Affecting Virulence, Tolerance, and Persistence
por: Savijoki, Kirsi, et al.
Publicado: (2021)

Food-Grade Bacteria Combat Pathogens by Blocking AHL-Mediated Quorum Sensing and Biofilm Formation
por: Savijoki, Kirsi, et al.
Publicado: (2022)

(+)-Dehydroabietic Acid, an Abietane-Type Diterpene, Inhibits Staphylococcus aureus Biofilms in Vitro
por: Fallarero, Adyary, et al.
Publicado: (2013)

Multisubstituted pyrimidines effectively inhibit bacterial growth and biofilm formation of Staphylococcus aureus
por: Provenzani, Riccardo, et al.
Publicado: (2021)

Structural and Functional Dynamics of Staphylococcus aureus Biofilms and Biofilm Matrix Proteins on Different Clinical Materials
por: Hiltunen, Anna K., et al.
Publicado: (2019)

Growth Mode and Physiological State of Cells Prior to Biofilm Formation Affect Immune Evasion and Persistence of Staphylococcus aureus
por: Savijoki, Kirsi, et al.
Publicado: (2020)

Prevention of Staphylococcus aureus biofilm formation by antibiotics in 96-Microtiter Well Plates and Drip Flow Reactors: critical factors influencing outcomes
por: Manner, Suvi, et al.
Publicado: (2017)

Anthranilamides with quinoline and β-carboline scaffolds: design, synthesis, and biological activity
por: Beus, Maja, et al.
Publicado: (2022)

Growth Mode and Carbon Source Impact the Surfaceome Dynamics of Lactobacillus rhamnosus GG
por: Savijoki, Kirsi, et al.
Publicado: (2019)

Systematic Exploration of Natural and Synthetic Flavonoids for the Inhibition of Staphylococcus aureus Biofilms
por: Manner, Suvi, et al.
Publicado: (2013)

Printed paper-based arrays as substrates for biofilm formation
por: Määttänen, Anni, et al.
Publicado: (2014)

384 Motives for kratom self-medication: contents of public comments solicited by the FDA
por: Tobacyk, Julia, et al.
Publicado: (2022)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Screening of Natural Product Derivatives Identifies Two Structurally Related Flavonoids as Potent Quorum Sensing Inhibitors against Gram-Negative Bacteria
por: Manner, Suvi, et al.
Publicado: (2018)

Experimental exposure assessment for in vitro cell-based bioassays in 96- and 384-well plates
por: Huchthausen, Julia, et al.
Publicado: (2023)

Interlaboratory study for the evaluation of three microtiter plate-based biofilm quantification methods
por: Allkja, Jontana, et al.
Publicado: (2021)

Flavones as Quorum Sensing Inhibitors Identified by a Newly Optimized Screening Platform Using Chromobacterium violaceum as Reporter Bacteria
por: Skogman, Malena E., et al.
Publicado: (2016)

Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization
por: Amen, Triana, et al.
Publicado: (2016)

Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

High-throughput formation and image-based analysis of basal-in mammary organoids in 384-well plates
por: Lee, Soojung, et al.
Publicado: (2022)

α,α-disubstituted β-amino amides eliminate Staphylococcus aureus biofilms by membrane disruption and biomass removal
por: Ausbacher, Dominik, et al.
Publicado: (2023)

FDA approved drugs as potential Ebola treatments
por: Ekins, Sean, et al.
Publicado: (2015)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
por: Sharma, Sushil, et al.
Publicado: (2011)

Seeking connectivity to everyday health and wellness experiences: Specificities and consequences of connective gaps in self-tracking data
por: Yli-Kauhaluoma, Sari, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cukv7tv8k61f4qo4cv45v3ufoe